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introduction: Fetal alcohol spectrum disorders (FASD) have an estimated global prev-
alence of 2–5% of births, but prevalence is reported to be as high as 15.5% for FASD 
in certain high-risk communities in South Africa. Preclinical studies demonstrate that 
alcohol consumption during pregnancy interferes with thyroid hormone availability and 
function and negatively impacts exposed offspring. Very little is currently reported on this 
phenomenon in humans.
Methods: This pilot study was embedded in the Drakenstein Child Health Study, a 
multi-disciplinary longitudinal birth cohort study investigating the early biological and 
psychosocial determinants of child health in South Africa. Twenty one mothers and their 
children with moderate–severe prenatal alcohol exposure (PAE) and 19 mothers and 
their children with no alcohol exposure were investigated. Maternal exposure history and 
blood samples were collected in mid-pregnancy and analyzed for serum-free thyroxin 
(FT4), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH). Children were 
assessed with formally measured growth parameters and development was evalu-
ated using the Bayley III Scales of Infant and Toddler Development (BSID III) at 6 and 
24 months of age.
results: While there were no significant differences in serum TSH and FT4 between 
groups, FT3 levels were significantly higher in mothers with moderate–severe prenatal 
alcohol use. In abstinent pregnant women, levels of FT4 were significantly correlated with 
infants’ scores on cognitive measures at 6 and 24 months of age and with levels of gross 
motor skills at 24 months. However, in mothers with alcohol use, FT4 levels were not 
correlated with any cognitive or motor skills, but FT3 levels were significantly associated 
with scores on children’s social-emotional development at 24 months of age.
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Discussion: Thyroid function in PAE is sufficiently disrupted to lead to alterations in 
serum FT3 levels. The contrast in findings between PAE and abstinent dyads in their 
association of maternal thyroid function and infant development further suggests that 
such disruption is present and may contribute to adverse neurodevelopment. Further 
work is needed to determine the relationship between peripheral thyroid indices during 
pregnancy and neurodevelopmental outcomes in the context of PAE.
Keywords: prenatal thyroid function, prenatal alcohol exposure, fetal alcohol spectrum disorders, infant 
development, pregnancy thyroid, thyroid function, Pae, child-development
inTrODUcTiOn
The World Health Organization (1) states that harmful alcohol 
usage ranks in the top five global contributors to disease, dis-
ability, and mortality. Fetal alcohol syndrome (FAS), the most 
severe of all fetal alcohol spectrum disorders (FASD), is further 
recognized as one of the major disease and disability categories 
within alcohol-related disorders (2, 3). The global prevalence 
of fetal FASD is estimated at 2–5% of births (4–7), but in South 
Africa, prevalence is reported to be as high as 6.3% for FAS and 
15.5% for FASD in certain high-risk communities (8).
Alcohol may directly harm the developing fetus, or act indi-
rectly by, among other mechanisms, suppressing maternal and 
fetal thyroid function (9–11). There are a number of preclinical 
studies, which demonstrate that maternal alcohol consumption 
during pregnancy interferes with thyroid hormone availability 
or function (12–18). In humans, excessive alcohol consumption 
may decrease serum levels of triiodothyronine (T3) (19, 20), 
thyroxine (T4) (21–23), free T3 (FT3), and free T4 (FT4) (24, 
25) and increase thyroid stimulating hormone (TSH) levels (26). 
Alcohol use during pregnancy has also been reported to lead to 
a significant suppression of newborn TSH levels (27, 28). One 
contrasting report found that newborn T4 and TSH values were 
considered normal, though demonstrated a wide range of values 
(T4: 2.7–42 µg/dl, and TSH: 3.0–114.0 ng/dl), perhaps reflecting 
the 48 h postpartum sampling range in this study (29). However, 
no prior work has reported on the relationship between thyroid 
function during pregnancy in alcohol dependent women and 
infant developmental outcomes.
Thyroid hormones are essential for normal healthy growth 
and neurodevelopment. The effect of subclinical hypothyroidism 
during the antenatal period on pregnancy outcomes has been a 
focus of attention (30–36). The largest study to date suggested 
an association of subclinical hypothyroidism with increased risk 
of premature delivery (37). Studies reporting on the effects of 
maternal thyroid hypofunction on fetal neurocognitive develop-
ment have yielded inconsistent findings including one highly 
powered study showing no significant adverse effect on the intel-
ligence quotient of 3- and 5-year-old children whose mothers had 
subclinical hypothyroidism in pregnancy (38, 39). In contrast, 
maternal subclinical hypothyroxinemia has overwhelmingly 
been reported as significantly associated with lower motor and 
intellectual development in children (40–53). While, a recent 
meta-analysis concluded that low maternal FT4 in pregnancy is 
associated with a threefold risk of delayed cognitive development 
in children (54), much remains to be learned about the relevant 
contributing mechanisms, particularly as it relates to maternal 
alcohol consumption. Our hypothesis is that alcohol consump-
tion in pregnancy alters not only the maternal thyroid function, 
but that of the mother–fetus dyad. Thus, child neurodevelopment 
of alcohol consuming mothers may be affected even if maternal 
thyroid hormone levels are within the normal range.
Animal studies have provided some important insights into 
the relationships between alcohol exposure during pregnancy 
and thyroid function. Such studies have identified that placental 
levels of the thyroid hormone metabolizing enzyme, iodothy-
ronine deiodinase 3 (Dio3), are increased following prenatal 
alcohol exposure (PAE) (14). Thus, with increased levels of 
placental Dio3, more T4 and T3 are metabolized into the biologi-
cally inactive reversed T3 and T2, respectively, leading to reduced 
amounts of T4 and T3 reaching the fetus. This is concerning, 
given the association between maternal FT4 levels and cognition 
of children at 3–5 years of age (52). The determining factor in thy-
roid hormone-dependent fetal brain development is the amount 
of the bioactive T3 in the brain, which is converted locally from 
T4. Since Dio3 expression is increased in the hippocampus of 
the PAE offspring, just as in the placenta, an additional decrease 
of hippocampal T3 is very likely, which is exaggerated by the 
reduced levels of T4 reaching the brain (16, 55, 56). These events 
can be precipitated by alcohol during development even in the 
face of adequate maternal peripheral T4 levels. Some of these 
mechanisms cannot be and others have not yet been explored 
in humans.
The current study investigated the impact of peripheral 
thyroid function of alcohol-consuming pregnant women on 
child developmental outcomes. We assessed serum FT4, FT3, 
and TSH levels in pregnant women with moderate to severe 
alcohol consumption and in those without significant alcohol 
consumption. We further assessed growth parameters at birth 
and neurodevelopmental outcomes of their children at 6 and 
24 months of age.
MaTerials anD MeThODs
Participants
The study was embedded in the Drakenstein Child Health Study 
(DCHS), a multi-disciplinary longitudinal birth cohort study 
investigating the early biological and psychosocial determinants 
of child health in two communities in the Western Cape Province, 
South Africa (57, 58). Both communities are largely low socio-
economic status and are characterized by a high prevalence of 
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psychosocial risk factors. These include high rates of drug and 
alcohol usage (57), maternal psychological distress and depres-
sion (59), community exposure to violence and intimate partner 
violence (60), and low levels of employment and educational 
attainment (57). The population is stable, with little immigration 
or emigration. In excess of 90% of people in the district use the 
public-sector health system.
The methods of the larger DCHS are described elsewhere 
(57, 58). Briefly, the cohort consisted of a South African sample of 
English, Afrikaans, or isiXhosa speaking mother–infant dyads. 
Mothers were recruited into this population-based cohort study 
from two clinics between March 2012 and March 2015 while 
attending for antenatal appointments. Women were enrolled in 
the DCHS at 20–28 weeks’ gestation and were followed through 
birth and postnatally. Pregnant mothers were considered eligi-
ble for inclusion if they were 18 years or older, were attending 
antenatal care at one of the two clinics and planned to remain 
resident in the region for at least 1  year. Mothers who were 
eligible and agreed to be included, provided informed written 
consent, in their preferred language, at enrollment and were 
re-consented annually following childbirth. Informed consent 
forms described the scope and aims of the study, including 
potential harm or benefits. The study was approved by the 
faculty of Health Sciences, Human Research Ethics Committee, 
University of Cape Town (401/2009), Stellenbosch University 
(N12/02/0002), and the Western Cape Provincial Health Research 
committee (2011RP45).
In this pilot study, 21 mothers and their children with moder-
ate–severe (PAE, as defined by mothers drinking at least twice 
a week and at least two drinks per occasion during any stage 
of pregnancy prior to recruitment) and 19 mothers and their 
children with no alcohol exposure (controls) were assessed for 
maternal thyroid function and child growth and developmental 
outcomes (61).
child assessment
Children were assessed by formally measured growth param-
eters, and a subgroup had their development evaluated using 
the Bayley III Scales of Infant Development (BSID III) at 6 
and 24  months of age (62). Assessors were blinded to alcohol 
and thyroid hormone status of the mothers. This assessment 
of infant development has been widely used globally and has 
been further validated in a South African population (63). The 
BSID-III consists of five subscales that were evaluated through 
direct observation by a trained assessor: cognitive, receptive 
language and expressive language, fine and gross motor. In addi-
tion, two additional scales were assessed through a caregiver 
questionnaire: Social-Emotional and Adaptive Behavior that 
can be used to indicate emotional and behavioral dysregulation. 
Scaled scores adjusted for age are reported, standardized mean 
10, SD 3. Quality control was performed on all the BSID-III 
assessments. Infants were excluded if born <36  weeks or had 
a low Apgar score (<7 at 5 min) and/or admission for hypoxic 
ischemic encephalopathy or other significant neonatal complica-
tion (such as neonatal jaundice requiring phototherapy). Infants 
were also excluded if they had an identified genetic syndrome or 
congenital abnormality.
Thyroid Function Measures
Maternal blood samples were collected in mid-pregnancy, 
in moderate to severe alcohol-consuming women (PAE) at 
5.36 ± 0.92 months, and in abstinent women at 5.18 ± 1.14 months 
of pregnancy.
For the thyroid function measurements, electrochemilumi-
nescence immunoassays “ECLIA” (Roche Diagnostics GmbH, 
D-68305 Mannheim) were used on the Elecsys e-immunoanalyz-
ers. The serum TSH assay measures 0.005–100 μIU/mL TSH with 
2–8% interassay coefficient of variation. The euthyroid values for 
non-pregnant test subjects are 0.270–4.20 μIU/mL, given by the 
manufacturer. The FT4 II assay can quantify 0.3–100  pmol/L 
FT4 with less than 4% interassay coefficient of variation. The 
euthyroid values for non-pregnant test subjects are given by the 
manufacturer as 12–22  pmol/L (2.5th and 97.5th percentile). 
Finally, the serum FT3 III assay range is 0.6–50 pmol/L FT3 with 
less than 3% interassay coefficient of variation. The euthyroid val-
ues for non-pregnant test subjects are given by the manufacturer 
as 3.1–6.8 pmol/L (2.5th and 97.5th percentile).
statistics
We generated descriptive statistics for maternal sociodemo-
graphic characteristics, infant anthropometric data, and BSID III 
Scaled Scores. The data were compared using Student’s t-tests for 
normally distributed continuous variables (e.g., maternal age), 
Pearson’s chi-square tests for categorical variables (e.g., ethnicity), 
and Mann–Whitney U tests for continuous variables that did not 
meet the assumptions for parametric testing (e.g., BSID Scaled 
Scores). Statistical analyses for this information was generated 
using SPSS (version 24).
Serum hormone levels in PAE and abstinent cases were com-
pared using Student’s t-test for the complete dataset or for the 
upper and lower 50th percentile in the case of serum TSH and 
FT4, respectively. Please note that Bonferroni correction was not 
applied in the descriptive statistics (Table 1) and in the maternal 
thyroid function data (Figure 1). A significant body of literature 
argues that while the Bonferroni correction directly targets the 
Type 1 error problem, it does so at the expense of Type 2 error. 
Therefore, many statisticians recommend reporting all of the 
individual p values and making it clear that no mathematical 
correction was made for multiple comparisons (64).
Pearson correlations were used to assess associations between 
serum hormone levels and child developmental measurements. 
FDR-corrections were employed for multiple comparisons, 
significance was set at p < 0.05. Linear regression analyses were 
carried out for maternal thyroid function measures and child 
developmental measures. Statistical analyses were carried out by 
Graphpad (Prism 7.0).
resUlTs
Table  1 presents the demographic characteristics of the study 
participants. The two groups of mothers were well matched for 
age and reasonably matched for ethnicity. Performance on the 
BSID III in this small cohort did not show significant group 
differences, with the exception of expressive communication 
TaBle 1 | Maternal demographic, infant anthropometric, and developmental 
characteristics.
alcohol 
exposed 
(n = 21)
controls 
(n = 19)
statistics
Maternal age (years, SD) 27.16 (6.01) 28.93 (5.80) t = −0.95, p = 0.35
Ethnicity (black/colored) 18/3 11/8 χ2 = 3.87, p = 0.05
Infant sex (male/female) 10/11 16/3 χ2 = 5.87, p = 0.02
Gestational age (weeks, SD) 38.43 (2.87) 38.63 (1.61) t = −0.27, p = 0.79
Birth weight (kg, SD) 2.69 (0.56) 3.12 (0.62) t = −2.27, p = 0.03
Length (cm, SD)a 48.65 (3.33) 50.79 (3.22) t = −2.04, p = 0.05
Head circumference  
(cm, SD)
32.33 (2.42) 34.04 (2.38) t = H2.25, p = 0.03
6m BsiD scaled scores
Cognitiveb 9.82 (2.23) 9.17 (2.12) U = 49.00, p = 0.32
Receptive communicationb 11.27 (2.49) 8.92 (2.31) U = 37.00, p = 0.08
Expressive communicationb 11.82 (2.36) 8.92 (3.68) U = 32.00, p = 0.04
Fine motorb 12.09 (1.92) 11.33 (3.11) U = 62.00, p = 0.83
Gross motorb 9.18 (3.68) 9.50 (1.62) U = 65.00, p = 0.98
Socio emotional  
developmentb
10.82 (2.82) 10.42 (3.70) U = 65.00, p = 0.98
24m BsiD scaled scores
Cognitivec 7.06 (2.01) 6.88 (1.71) U = 116.00, p = 0.49
Receptive communicationd 6.94 (1.61) 6.81 (1.97) U = 127.00, p = 0.99
Expressive communicatione 7.27 (1.87) 7.19 (1.87) U = 112.00, p = 0.77
Fine motorc 8.76 (2.68) 9.81 (3.25) U = 109.50, p = 0.34
Gross motorf 8.13 (2.90) 9.07 (2.66) U = 83.50, p = 0.15
Socioemotional  
developmentc
13.76 (3.13) 12.50 (3.06) U = 107.50, p = 0.31
aData missing for single alcohol exposed participant.
bData missing for 10 alcohol exposed and 7 healthy unexposed (control) participants.
cData missing for 4 alcohol exposed and 3 healthy unexposed (control) participants.
dData missing for 5 alcohol exposed and 3 healthy unexposed (control) participants.
eData missing for 6 alcohol exposed and 3 healthy unexposed (control) participants.
fData missing for 5 alcohol exposed and 4 healthy unexposed (control) participants.
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at 6  months of age, but this pilot study was not designed or 
adequately powered to address this particular question.
Thyroid function of the pregnant women was assessed by 
serum TSH, FT4, and FT3 measurements. One women from 
the PAE group and two from the abstinent group had serum 
TSH levels above 3.5 mIU/L (3.65, 3.57, and 5.76 mIU/L), and 
so were removed from the dataset. The histograms of serum 
TSH and FT4 (Figures  1A,C) show the propensity of TSH 
values to spread toward the higher, and FT4 levels toward 
the lower levels in the PAE pregnant women. TSH levels did 
not show significant differences between PAE and abstinent 
women (Figure 1B). However, while FT4 levels did not differ 
between the groups, the lower 50th percentile of FT4 values 
were significantly lower in the PAE compared to abstinent 
women [t(17) = 4.6, p < 0.01;  Figure 1D]. Similarly, the TSH to 
FT4 ratio tended to be greater in the PAE group [t(36) = 1.86, 
p =  0.07; Figure  1E], consistent with an exaggeration in the 
inverse relationship of serum TSH and FT4 in the PAE group. 
In contrast to FT4, serum FT3 levels were significantly higher 
in the PAE group compared to abstinent pregnant women 
[whole group: t(36) =  2.30, p <  0.05; lowest 50th percentile: 
t(17) = 2.20, p < 0.05; Figure 1F]. The increased serum levels 
of FT3 and unchanged or decreased FT4 suggest enhanced T4 
to T3 conversion in the periphery.
We investigated the maternal thyroid function and infant 
developmental measures separately for abstinent women and 
infant dyad and for the alcohol-consuming mother infant dyad. 
As alcohol affects not only maternal thyroid function but also the 
developing fetus combining abstinent and alcohol-consuming 
mothers’ thyroid indices and their infants’ developmental meas-
ures may be misleading. In the abstinent women, correlation 
between maternal thyroid hormone indices during pregnancy 
and newborn and child measures found that increased maternal 
FT4 is significantly associated with greater scores on cognitive 
measures at 6 and 24  months of age and with increased per-
formance in gross motor skills at 24  months of age (Table  2). 
In contrast, these relationships were not found in PAE dyads 
(Table  3), but in this group maternal FT3 levels significantly 
correlated with children’s social-emotional developmental scores 
at 24 months of age. Linear regression analyses between maternal 
FT4 and TSH, and cognitive, and language developmental mea-
sures of their children at 6 months of age are shown in Figure 2. 
Higher maternal FT4 levels in abstinent pregnant women predict 
greater cognitive and communicative functions of their children 
at 6 month of age [cognition 6 m: F(1, 10) = 6.08; p < 0.05; recep-
tive communication 6 m: F(1, 10) = 9.09; p = 0.01; Figure 2A]. 
Maternal serum TSH shows the predicted inverse trend with these 
measures, albeit not significantly [cognition 6 m: F(1, 10) = 3.67; 
p = 0.08; receptive communication 6 m: F(1, 10) = 2.06; p = 0.18; 
Figure  2B]. Neither FT4 nor TSH of the pregnant alcohol-
consuming women showed a significant relationship with these 
measures, which displayed a distinctly greater scatter than in the 
abstinent dyads as represented in Figures 2C,D.
DiscUssiOn
This pilot study suggests that moderate-to-severe alcohol con-
sumption during pregnancy is associated with alterations in 
maternal thyroid function, particularly with increased serum 
FT3 levels. Increased serum FT4 levels in abstinent pregnant 
women are significantly associated with higher scores on cogni-
tive measures in early childhood in their children. In contrast, 
in women with moderate-to-severe alcohol consumption, this 
association is not present, but instead, increased serum FT3 
levels are significantly associated with altered social-emotional 
development at 24 months of age.
Altered thyroid function in pregnant women who consumed 
alcohol was reflected in increased FT3. Furthermore, serum TSH 
tended to be higher, and FT4 tended to be lower in PAE women. 
Increased serum FT3 in alcohol consuming pregnant women is 
a novel and unexpected finding. In the light of the tendency of 
alcohol lowering FT4, increased serum FT3 levels could be due to 
greater proportion of T4 converted to T3 by increased expression of 
deiodinase 2 (Dio2) after alcohol exposure. Chronic alcohol 
exposure is known to increase deiodinase 1 in the liver (65) and 
deiodinase 2 in the pituitary and the frontal cortex (66) as well as the 
amygdala (67). Furthermore, in a positive feedforward regulation, 
T3 is known to induce Dio2 expression in brain regions (68) and in 
the brown adipose tissue as well (69). An example of how increased 
Dio2 can coexist with decreased T4 and increased T3, at least in the 
brain, is shown by the effects of a single dose lithium (67).
FigUre 1 | Thyroid function in pregnant women. The distribution is shifted toward higher levels of serum TSH (a), toward lower levels of FT4 (c), and greater ratio 
of TSH/FT4 (e) in pregnant women with moderate to severe alcohol consumption [prenatal alcohol exposure (PAE)] compared to no alcohol use women (Controls). 
Means and SEM of serum (B) TSH, (D) FT4, and (F) FT3 levels in PAE and control women, and the highest 50th percentile of TSH, lowest 50th percentile FT4 and 
FT3, respectively. *p < 0.05; **p < 0.01. Trending significance is shown by the actual p-value.
TaBle 2 | Correlation coefficients (Pearson) between thyroid function measures in abstinent pregnant women and their children’s birth and neurobehavioral parameters.
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12 13. 14. 15. 16. 17.
1. Mat TSH
2. Mat fT4 0.231
3. Mat fT3 −0.175 0.345
4. Birth weight −0.483 −0.242 0.390
5. Birth length −0.153 −0.103 −0.023 0.577*
6. Head circum. −0.209 −0.004 0.331 0.776* 0.287
7. Cogn 6m −0.518 0.615# −0.016 0.123 0.341 0.218
8. Rec Comm 6m −0.413 0.690* 0.025 −0.064 0.307 0.019 0.825*
9. Expr Comm 6m −0.557 0.356 0.427 0.405 0.585 −0.023 0.123 0.363
10. Fine motor 6m −0.571 0.200 0.212 0.189 0.489 −0.148 0.262 0.450 0.700*
11. Gross motor 6m −0.014 −0.393 −0.014 0.237 0.458 0.098 0.000 0.077 0.221 0.703*
12. Soc Emot Dev 6m −0.349 0.232 0.122 0.134 0.366 −0.068 0.356 0.215 0.184 0.473 0.309
13. Cogn 24m −0.032 −0.231 0.029 0.402 0.492 0.483 0.227 0.354 −0.011 −0.154 −0.018 −0.178
14. Rec Comm 24m −0.259 0.382 0.433# 0.167 0.011 0.319 0.603# 0.713* 0.038 0.076 −0.074 0.014 0.391
15. Expr Comm 24m 0.442 0.582*−0.048 −0.556*−0.503 −0.245 0.032 0.298 0.022 −0.231 −0.368 −0.215 −0.117 0.398
16. Fine motor 24m −0.095 0.110 −0.015 0.367 0.416 0.321 0.363 0.416 0.257 0.239 0.136 0.079 0.560* 0.545# 0.218
17. Gross motor 24m −0.034 0.514# 0.112 0.090 −0.126 0.361 0.563 0.520 0.011 −0.266 −0.293 −0.472 0.049 0.604* 0.522# 0.422
18. Soc Emot Dev 24m −0.072 0.101 0.345 0.148 0.168 0.182 0.128 0.123 0.287 0.247 0.232 −0.076 0.178 0.313 0.151 0.116 –0.032
FDR corrected p-values *p < 0.02; #p < 0.04 for significant and trending, respectively.
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TaBle 3 | Correlation coefficients (Pearson) between thyroid function measures in the moderate to severe alcohol consuming pregnant women and their children’s birth 
and neurobehavioral parameters.
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17.
1. Mat TSH
2. Matf T4 0.225
3. Matf T3 −0.136 0.327
4. Birth weight −0.326 0.366 0.348
5. Birth length −0.015 0.277 0.354 0.740*
6. Head Circum −0.323 0.116 0.141 0.838* 0.523*
7. Cogn 6m 0.437 0.578 0.392 0.603 0.488 0.404
8. Rec Comm 6m 0.190 0.411 0.468 0.418 0.386 0.491 0.205
9. Expr Comm 6m 0.095 0.504 0.322 0.711* 0.758* 0.477 0.722* 0.256
10. Fine motor 6m 0.364 0.546 0.433 0.722* 0.804* 0.641# 0.793* 0.485 0.887*
11. Gross motor 6m −0.160 0.321 0.408 0.448 0.446 0.559 0.086 −0.010 0.538 0.442
12. Soc Emot Dev 6m 0.104 −0.351 −0.120 −0.218 0.249 −0.026 −0.282 0.100 −0.039 0.166 0.247
13. Cogn 24m −0.294 0.062 0.460 0.383 0.303 0.131 −0.056 0.459 0.452 0.397 0.662 0.203
14. Rec Comm 24m −0.419 0.416 0.512 0.488 0.558# 0.316 0.188 0.531 0.648 0.587 0.700# −0.072 0.677*
15. Expr Comm 24m −0.084 0.244 0.446 0.586# 0.547# 0.174 0.290 0.422 0.613 0.571 0.466 −0.221 0.754* 0.797*
16. Fine motor 24m −0.134 0.095 0.232 0.415 0.201 0.245 0.513 −0.456 0.728# 0.402 0.590 −0.399 0.241 0.325 0.327
17. Gross motor 24m −0.176 −0.176 0.418 0.072 −0.105 0.268 −0.075 0.303 −0.099 −0.023 0.280 −0.136 0.483 0.328 0.323 0.174
18. Soc Emot Dev 24m −0.015 0.280 0.569* 0.369 0.259 0.477 0.465 0.579 0.428 0.725# 0.574  0.259 0.233 0.514 0.226 0.352 0.436
FDR corrected p-values *p < 0.02; #p < 0.04 for significant and trending, respectively. Red: gained significance compared to control group, blue: lost significance compared to 
control group.
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FigUre 2 | Alcohol consumption interferes with the predictive association between maternal thyroid measures and child development. Linear regression analyses 
between maternal serum FT4 and TSH, and cognitive, and language developmental measures of their children at 6 months of age in women abstinent during 
pregnancy (a,B) and pregnant women with moderate to severe alcohol consumption (c,D).
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“excessively friendly and fearless” (91), “friendly and trusting 
with strangers” (92), thus clearly indicating differences in their 
emotional, social development from the control population. This 
verbal, but impulsive, disposition may be the signature that is 
being picked up in this domain (93). The actual items measured 
in this domain at this age include requesting physical and social 
need through verbal or visual means. Thus, a more demanding or 
forceful child may score highly on these particular items without 
socio-emotional flexibility, which is one of the hallmark deficits 
of the FASD profile. As with all early developmental outcome 
studies, the answers may only manifest with larger samples.
A number of limitations to this pilot study should be empha-
sized. In particular, the small sample size, the lack of maternal 
thyroid indices at earlier time points in pregnancy and additional 
measurements of peripheral thyroid function, resulting in the 
conservative interpretation of the findings. Nevertheless, these 
are the first data to report child developmental outcomes in 
relation to maternal thyroid indices in the context of PAE. These 
findings are supported by animal work where thyroid hormone 
efficacy and metabolism is affected by alcohol exposure during 
pregnancy with an impact on the offspring cognitive outcomes 
compared to those infants born to non-alcohol consuming 
mothers (55, 56). Future studies, in addition to expanding the 
sample size, will investigate changes in maternal and child thyroid 
hormone profile in the context of PAE and in healthy unexposed 
pregnancies over the course of pregnancy. Additionally, longi-
tudinal developmental trajectories into later childhood should 
be used to investigate the mediating role of thyroid function 
in pregnancy on child development in future studies involving 
abstinent and moderate to severe alcohol consuming women.
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Importantly, with greater T4 to T3 conversion in the periph-
ery, less T4 is available to cross to the placenta to the fetal brain. 
Since only a portion of brain T3 originates from the periphery 
and the main source is local conversion from T4, the potentially 
reduced amount of T4 reaching the fetal brain can induce a state 
of hypothyroidism in the fetal brain. Furthermore, some thyroid 
hormone transporters prefer T4 to T3; therefore, brain region-
specific hypothyroidism can occur in the presence of decreased 
serum FT4 and elevated FT3 (70). Interestingly, decreased serum 
FT4 and increased FT3 has been described in patients with post-
traumatic stress disorder (PTSD) (71) and in women at risk for 
postpartum depression (72). Whether that finding is related to 
alteration in cortisol levels in subjects with PTSD (73), which 
is also known to occur in alcohol consuming pregnant animals 
(74, 75) is not known. Additionally, elevated FT3 has been shown 
to correlate with increases in preterm birth (76), which is very 
frequent in PAE pregnancies.
The finding here of a correlation between FT4 and cognitive 
outcomes is consistent with much work showing the reverse 
relationship: adverse outcomes in children born to mothers 
with isolated hypothyroxinemia (30, 35, 38, 40, 41, 50, 77–90). 
Adverse outcomes of hypothyroxinemia reported in populations 
across the world, include prematurity, lower IQ, general cognitive 
developmental deficit, language delay, impaired motor function, 
smaller head circumference among others. In the present study, 
serum FT4 levels of abstinent women in pregnancy were linearly 
correlated with their children’s cognitive performance in infancy 
in the predicted direction. However, this seemingly direct linear 
relationship between euthyroxinemic maternal milieu and child 
cognitive development was abolished by alcohol consumption 
during pregnancy in our pilot cohort. The possibility that an 
increased proportion of FT4 converted to FT3 in the PAE women 
suggests potentially decreased FT4 crossing into the placenta. 
Should placental levels of DIO3 be increased after PAE in humans, 
as it has been shown in animal studies, even less FT4 and FT3 
would reach the fetus. Thus, even in the context of non-significant 
differences in FT4, in the presence of PAE during this important 
developmental window, the placental transfer of FT4 and fetal 
thyroid hormone utilization may differ. Whether subclinical 
hypothyroidism or hypothyroxinaemia during pregnancy is an 
additional risk factor for alcohol-induced neurodevelopmental 
disorder is important to explore. Unfortunately, there remains 
great controversy about the significance of subclinical hypothy-
roidism in general, but in pregnancy, in particular. Should alcohol 
consumption in pregnancy alter not only the maternal thyroid 
function but that of the mother–fetus dyad, then neurodevelop-
ment of the children alcohol consuming mothers may be affected 
even in the presence of maternal thyroid hormone levels within 
the normal range. This is the proposed potential mechanism 
(at least in part) for the effects of alcohol exposure on the deve-
loping fetus, and a potential pathway for treatment.
The finding of linear association between the elevated serum 
FT3 levels in the alcohol consuming pregnant women and their 
infant’s social and emotional development is difficult to interpret. 
Without detailed interpretation of this developmental measure-
ment, one can venture the opinion that this relationship may 
cover multiple aspects of emotional development. Specifically, 
very young children with FASD have been described as being 
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